Right trisectionectomy of the liver for intrahepatic cholangiocarcinoma with bile duct invasion in a Jehovah's Witness.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 17520209)

Published in J Hepatobiliary Pancreat Surg on May 29, 2007

Authors

Seigo Nishida1, Juan R Madariaga, Sergio Santiago, Cristiano Quintini, Emmanouil Palaios, Anthony Gyamfi, Rafael Rico, Keisuke Hamamura, Hani Haider, Jang I Moon, David M Levi, Victor J Casillas, Pablo A Bejarano, Andreas G Tzakis

Author Affiliations

1: Division of Transplantation, Department of Surgery, Miller School of Medicine, University of Miami/Jackson Memorial Medical Center, 1801 NW 9th Avenue, Suite 514, Miami, Florida 33136, USA.

Articles by these authors

When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases. Ann Surg (2014) 2.23

Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors. Liver Int (2008) 2.15

The perforated duodenal diverticulum. Arch Surg (2012) 2.14

Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience. Liver Transpl (2015) 2.03

Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature. Mod Pathol (2002) 1.65

Intestinal transplantation for the treatment of neoplastic disease. J Surg Oncol (2005) 1.62

Heterotopic uterus transplantation in a swine model. Transplantation (2009) 1.59

Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology (2002) 1.55

Transplantation of the abdominal wall. Lancet (2003) 1.51

Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol (2005) 1.48

Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl (2013) 1.47

Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Liver Transpl (2004) 1.42

Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation. Transplantation (2002) 1.42

Analysis of vascular access in intestinal transplant recipients using the Miami classification from the VIIIth International Small Bowel Transplant Symposium. Transplantation (2005) 1.40

Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol (2008) 1.40

Three-dimensional print of a liver for preoperative planning in living donor liver transplantation. Liver Transpl (2013) 1.39

100 multivisceral transplants at a single center. Ann Surg (2005) 1.34

A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation (2004) 1.30

Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation (2003) 1.28

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation (2005) 1.25

Low-grade fibromyxoid sarcoma: a brief review. Arch Pathol Lab Med (2006) 1.25

Intestinal and multivisceral transplantation. World J Surg (2001) 1.25

Impact of biliary complications in right lobe living donor liver transplantation. Transpl Int (2006) 1.23

Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl (2004) 1.22

Intestinal and multivisceral transplantation in children. Ann Surg (2006) 1.22

Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation (2006) 1.22

Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg (2011) 1.19

Comparison of long-term numerical and experimental total knee replacement wear during simulated gait loading. J Biomech (2006) 1.17

Large esophageal liposarcoma: a case report and review of the literature. Arch Pathol Lab Med (2004) 1.17

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc (2002) 1.16

Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients. Transplantation (2002) 1.11

TLR4 activates the β-catenin pathway to cause intestinal neoplasia. PLoS One (2013) 1.10

Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation (2011) 1.06

Intrahepatic biliary strictures after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.05

Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity. Cancer Res (2011) 1.05

Surgical therapy for hepatolithiasis: a Western experience. J Am Coll Surg (2005) 1.03

Donor intracaval thrombus formation and pulmonary embolism after simultaneous piggyback liver transplantation and aortic valve replacement. Clin Transplant (2003) 1.02

The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant (2005) 1.01

Ameloblastic carcinosarcoma of the mandible arising in ameloblastic fibroma: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 1.01

Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. J Pediatr Gastroenterol Nutr (2006) 1.01

The use of Campath-1H as induction therapy in renal transplantation: preliminary results. Transplantation (2004) 0.99

Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation (2004) 0.99

Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg (2010) 0.98

Ninety-five cases of intestinal transplantation at the University of Miami. J Gastrointest Surg (2002) 0.98

Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer (2002) 0.97

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl (2003) 0.97

Piggyback technique in adult orthotopic liver transplantation: an analysis of 1067 liver transplants at a single center. HPB (Oxford) (2006) 0.95

Propylthiouracil-induced acute liver failure: role of liver transplantation. Int J Endocrinol (2010) 0.95

Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation. Transplantation (2011) 0.95

Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation. Transpl Immunol (2003) 0.95

The effect of immunosuppression on peritoneal adhesions formation after small bowel transplantation in rats. J Surg Res (2007) 0.95

Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy. Transplantation (2004) 0.94

Cystic lesions of the pancreas: clinical and pathologic review of cases in a five year period. JOP (2010) 0.94

Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant (2010) 0.93

Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. Transplantation (2003) 0.93

Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. J Am Coll Surg (2010) 0.92

Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. J Am Coll Surg (2003) 0.92

Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastroenterol (2003) 0.91

Use of a branch patch with the cystic artery in living-related liver transplantation. Clin Transplant (2004) 0.91

Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl (2004) 0.91

Eosinophilic cholangiopathy with concurrent eosinophilic colitis in a patient with idiopathic hypereosinophilic syndrome. Eur J Gastroenterol Hepatol (2008) 0.91

Adenomyomatous hyperplasia of the gallbladder with perineural invasion: revisited. Am J Surg Pathol (2007) 0.91

A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection. Liver Transpl (2003) 0.90

Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form. J Biol Chem (2010) 0.90

Liver transplantation for severe hepatic trauma: experience from a single center. World J Gastroenterol (2009) 0.90

Gastroduodenal artery steal syndrome during liver transplantation: intraoperative diagnosis with Doppler ultrasound and management. Transpl Int (2005) 0.90

Intestinal and multivisceral transplantation in children with severe gastrointestinal dysmotility. J Pediatr Surg (2005) 0.90

Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Transplantation (2003) 0.89

Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival. Transplantation (2012) 0.89

Oncocytic papillary neoplasms of the biliary tract: a clinicopathological, mucin core and Wnt pathway protein analysis of four cases. Pathology (2007) 0.89

Long-term deleterious effects of aortohepatic conduits in primary liver transplantation: proceed with caution. Liver Transpl (2013) 0.88

Age-related comparison of the profiles of patients with hepatocellular carcinoma. Hepatogastroenterology (2006) 0.88